These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25093735)

  • 1. The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database.
    Pradier C; Sakarovitch C; Le Duff F; Layese R; Metelkina A; Anthony S; Tifratene K; Robert P
    PLoS One; 2014; 9(8):e103630. PubMed ID: 25093735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.
    Le Duff F; Develay AE; Quetel J; Lafay P; Schück S; Pradier C; Robert P;
    J Alzheimers Dis; 2012; 29(4):891-902. PubMed ID: 22366771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease.
    Law S; Wolfson C
    Br J Psychiatry; 1995 Oct; 167(4):541-4. PubMed ID: 8829727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The French National Alzheimer database: a fast growing database for researchers and clinicians.
    Anthony S; Pradier C; Chevrier R; Festraëts J; Tifratene K; Robert P
    Dement Geriatr Cogn Disord; 2014; 38(5-6):271-80. PubMed ID: 24994018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
    Epelbaum S; Paquet C; Hugon J; Dumurgier J; Wallon D; Hannequin D; Jonveaux T; Besozzi A; Pouponneau S; Hommet C; Blanc F; Berly L; Julian A; Paccalin M; Pasquier F; Bellet J; Boutoleau-Bretonniere C; Charriau T; Rouaud O; Madec O; Mouton A; David R; Bekadar S; Fabre R; Liegey E; Deberdt W; Robert P; Dubois B
    BMJ Open; 2019 Jun; 9(6):e029663. PubMed ID: 31239309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of education and socioeconomic status with the Mini Mental State Examination and the clinical diagnosis of dementia in elderly people.
    Brayne C; Calloway P
    Age Ageing; 1990 Mar; 19(2):91-6. PubMed ID: 2337015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, education, and changes in the Mini-Mental State Exam scores of older women: findings from the Nun Study.
    Butler SM; Ashford JW; Snowdon DA
    J Am Geriatr Soc; 1996 Jun; 44(6):675-81. PubMed ID: 8642159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA).
    Tifratene K; Sakarovitch C; Rouis A; Pradier C; Robert P
    J Alzheimers Dis; 2014; 38(3):541-9. PubMed ID: 24018266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the impact of age, gender and educational level on cognitive function in Alzheimer's disease: A quantitative approach.
    Delpak A; Talebi M
    Arch Gerontol Geriatr; 2020; 89():104090. PubMed ID: 32388335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease.
    Galasko D; Klauber MR; Hofstetter CR; Salmon DP; Lasker B; Thal LJ
    Arch Neurol; 1990 Jan; 47(1):49-52. PubMed ID: 2294894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia.
    Fritsch T; McClendon MJ; Smyth KA; Ogrocki PK
    Int Psychogeriatr; 2002 Dec; 14(4):347-63. PubMed ID: 12670057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA).
    Herr M; Ankri J; Diard C; Hiance-Delahaye A
    Drugs Aging; 2021 Jan; 38(1):63-74. PubMed ID: 33410119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling mini mental state examination changes in Alzheimer's disease.
    Mendiondo MS; Ashford JW; Kryscio RJ; Schmitt FA
    Stat Med; 2000 Jun 15-30; 19(11-12):1607-16. PubMed ID: 10844722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.
    Soto ME; Secher M; Gillette-Guyonnet S; Abellan van Kan G; Andrieu S; Nourhashemi F; Rolland Y; Vellas B
    J Alzheimers Dis; 2012; 28(3):647-54. PubMed ID: 22045479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database.
    Spering CC; Hobson V; Lucas JA; Menon CV; Hall JR; O'Bryant SE
    J Gerontol A Biol Sci Med Sci; 2012 Aug; 67(8):890-6. PubMed ID: 22396476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.